Insider Shareholders with Indirect Ownership of Royalty Pharma PLC (RPRX)
This section provides a comprehensive overview of the insiders with indirect ownership of Royalty Pharma PLC (RPRX). You can find the latest updates on their holdings.
Royalty Pharma plc Insider List
| Insider | Adquired | Disposed | # of Trades |
|---|---|---|---|
|
Legorreta Pablo G.
CEO, Chairman of the Board |
4,401,170 | 462,031 | 12 |
|
Rory B Riggs
Director |
2,628,840 | 7,696,433 | 12 |
|
Henry A Fernandez
Director |
58,200 | 0 | 2 |
|
Christopher Hite
EVP & Vice Chairman |
658,510 | 0 | 5 |
| 0 | 2,447,068 | 14 | |
|
Marshall Urist
EVP, Research & Investments |
160,000 | 106,667 | 6 |
|
William E Ford
Director |
581,870 | 42,101 | 2 |
|
George W. Lloyd
EVP, Investments & CLO |
2,584,370 | 2,082,426 | 45 |
|
Terrance P. Coyne
EVP & CFO |
1,458,510 | 688,340 | 18 |
|
Adage Capital Partners Gp, L.L.C.
> 10% Shareholder |
46,015,330 | 7,301,050 | 3 |
| 0 | 1,154,986 | 6 | |
| 0 | 345,014 | 2 | |
|
James F. Reddoch
EVP & Chief Scientific Officer |
1,720,800 | 908,949 | 21 |
| 0 | 1,000,000 | 6 | |